Celiac Disease Comprehensive Panel

The Celiac Disease Comprehensive Panel evaluates for celiac disease by measuring key antibodies associated with an immune response to gluten and assessing markers that help ensure accurate test interpretation. This panel typically includes tissue transglutaminase (tTG) antibodies, deamidated gliadin peptide (DGP) antibodies, and total immunoglobulin A (IgA), with additional testing performed when indicated. It is commonly used to investigate symptoms such as chronic diarrhea, abdominal pain, bloating, unexplained weight loss, iron deficiency, or malabsorption. Results help identify individuals with celiac disease, support diagnosis, and guide decisions regarding further evaluation, dietary management, and long-term monitoring.